Skip to content

The effect of casein phosphopeptide - amorphous calcium phosphate on saliva

The effect of casein phosphopeptide - amorphous calcium phosphate on salivary flow rate, salivary pH and salivary calcium concentration in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17509082
Enrollment
50
Registered
2022-11-22
Start date
2021-12-01
Completion date
Unknown
Last updated
2023-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Remineralization capacity of CPP-ACP Oral Health

Interventions

Participants will be allocated equally into two groups: Group 1 (intervention) receive GC Tooth Mousse (CPP-ACP) and Group 2 (control) receive a placebo mousse. A random allocation li

Sponsors

Damascus University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Good oral hygiene 2. Participants not be taking antibiotics or any kind of medications that can affect the flow rate of saliva 3. Does not suffer from an allergy to milk protein confirmed or suspected and/or the presence of the sensitivity of benzoate (preservative)

Exclusion criteria

Exclusion criteria: 1. Taking antibiotics or drugs that may affect the salivary flow rate 2. The existence of diseases that may affect the flow rate of saliva or a combination such as diabetes 3. Sensitivity to milk protein confirmed or suspected and/or the presence of the sensitivity of benzoate (preservative)

Design outcomes

Primary

MeasureTime frame
Measured at T0: before the application (baseline); T1: directly after the application ; T2: after half an hour; T3: after 1 hour: 1. pH of saliva measured using pH test strips (Whatman® Panpeha™ pH indicator strips) 2. Salivary flow rate measured by calculating the amount of saliva which will be collected in tubes and dividing it into five to see the amount of saliva secreted per minute (ml/d)

Secondary

MeasureTime frame
Calcium concentration of saliva measured using Calein as an indicator, ethylenediaminetetra-acetate (EDTA) as a Ca-complexing agent, and a standard Ca solution to set up the calibration series; measured at T0: before the application (baseline); T1: directly after the application ; T2: after half an hour; T3: after 1 hour.

Countries

Syria

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 11, 2026